IP Library › Granted Patent US 10,058,710
Granted Patent B2
US 10,058,710 · App. 14/888,756 · Granted Aug 28, 2018

Device and method for reducing the permeability of the cornea

Inventors: Ifat Sher-Rosenthal (Shoham, IL); Ygal Rotenstreich (Kfar Bilu, IL)
Assignee: Tel Hashomer Medical Research Infrastructure and Services Ltd.
A61N2/006A61F9/00A61N2/004A61N2/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,058,710
App. No.
14/888,756
Granted
Aug 28, 2018
Kind
B2
Abstract

The present invention provides a device and a method for non-invasively enhancing the integrity of the cornea by applying a magnetic field, thereby treating eye disorders.

Claims (6)

1. A method of treating an eye of a subject, comprising i) applying a changing magnetic field; ii) measuring penetration of fluorescein from the corneal surface to anterior chamber of said eye; and iii) selecting a magnetic field strength sufficient to reduce corneal permeability.

2. The method of claim 1 , wherein the corneal permeability is reduced by the magnetic field, thereby protecting the eye against entrance of noxious agents or against loss of water.

3. The method of claim 1 , comprising repetitively applying said magnetic field to the eye of said subject in need of said treating, thereby reducing the corneal permeability.

4. The method of claim 1 , comprising treating or preventing conditions selected from the group consisting of keratitis sicca, eye dryness, corneal epithelial dysfunctions, corneal keratitis, reduced barrier function of the cornea associated with diabetes, conditions associated with increased corneal permeability due to ageing, minor lesions of the corneal surface, conditions associated with wearing contact lenses, reduced self-healing capabilities of the cornea, and penetration of harmful agents to the eye from a contaminated environment.

5. The method of claim 1 , wherein said strength is sufficient to reduce the corneal permeability as measured by the penetration of fluorescein from the corneal surface to the anterior chamber.

6. The method of claim 1 , comprising treating eye dryness.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2015
From: SHER-ROSENTHAL, IFAT; ROTENSTREICH, YGAL
To: TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
Reel/Frame 036945/0046 →
Priority Claims (1)
IL 226180 · May 6, 2013 · national
Continuity (1)
Related Publication 20160106996A1 · Apr 21, 2016